Perlmutter Cancer Center at NYU Langone Health

We combine visionary thinking and compassionate care with the science of treating cancer. An NCI-designated Comprehensive Cancer Center, part of @NYULangone

[Perlmutter Cancer Center at NYU Langone Health @Perlmutter_CC]

Today at #ESMO2026, PCC’s Kristen Spencer, DO, (@kspencer725) presents research on novel targeted therapies for colorectal cancer, including KRAS G12D inhibitors and treatment approaches for MCC CRC.

@myESMO @nyugrossman

[Doctor Radio @NYUDocs]

Tune in at 2:30pm as @DrMarcSiegel talks about a groundbreaking potential treatment for #melanoma & the evolution of cancer vaccines with @nyulangone @Perlmutter_CC's Dr. Janice Mehnert, MD @JaniceM10. Stream online here: https://t.co/vuGRUcZZvE

[Perlmutter Cancer Center at NYU Langone Health @Perlmutter_CC]

We're proud to highlight the outstanding research being presented by @NYULangone experts at #ESMO2026 in Madrid, Spain.

Today Bhavana Pothuri, MD, (@BPothuri) discusses unmet needs after immunotherapy & evolving clinical practices for endometrial cancer. @myESMO @nyugrossman

[NYU Grossman School of Medicine @nyugrossman]

At #ESMO26, our oncology experts will present on investigational immunotherapy, gastrointestinal cancers, non-metastatic lung cancer, and other thoracic malignancies.

See the full list of @nyulangone physicians participating: https://t.co/5yOYbv6WKA

[Perlmutter Cancer Center at NYU Langone Health @Perlmutter_CC]

Watch the recording of our latest #PatientEducation webinar on #TripleNegativeBreastCancer to learn about treatment options, the latest research, and follow-up care: https://t.co/0i66af8OdL

[Perlmutter Cancer Center at NYU Langone Health @Perlmutter_CC]

The treatment landscape for #TripleNegativeBreastCancer, an aggressive #BreastCancer subtype, is rapidly evolving. Join experts to discuss current & emerging treatment approaches, the latest research & follow-up care.
@NaomiKoMD @RichPossemato #TNBC

RSVP: https://t.co/D4UYKqU7KZ

[Anirban Maitra @Aiims1742]

Beyond excited to recruit @VivekSubbiah to @nyulangone @Perlmutter_CC as the new director of our Early Phase Drug Development Program and the Rare Cancer Program.
Congratulate Vivek when you see him at #ESMO26. Welcome to NYC!
@JohnPLeonardMD
https://t.co/sJKbZI0PDc

[Jane Skok @jane_skok]

● From scientific curiosity to potential medicine. Dr. Isaac Klein (Dewpoint Therapeutics) explores how biomolecular condensates are creating new opportunities to reach challenging drug targets—and what it takes to turn that biology into therapies ready for the clinic! Register

[NYUGSOM Hematology & Medical Oncology Fellowship @NYUGSOM_HemeOnc]

This evening, the NYU heme/onc fellowship and @Perlmutter_CC said farewell to @minaseconomides, one of our most beloved and appreciated faculty members. It was great for the fellows and faculty to get together for a few drinks and snacks tonight!

[OncLive.com @OncLive]

WATCH 📺: @md_oberstein, of @Perlmutter_CC, discusses the rationale for the anti-PD-1/IL-15 fusion protein SAR445877 in microsatellite-stable colorectal cancer. #crcsm #oncology

Full video ➡️: https://t.co/zdzPUoLqIM

[NYU Grossman School of Medicine @nyugrossman]

A study of more than 54,000 patients with IBD found that precancerous changes were linked to higher colorectal cancer risk. The findings could help refine colonoscopy surveillance guidelines and support more personalized care.

Read more ⤵️ https://t.co/4tvHbnXoc8

[Doctor Radio @NYUDocs]

Coming up at 2:30pm East, @DrMarcSiegel explores the latest, groundbreaking advances in #melanoma treatment & the evolution of cancer vaccines with @nyulangone @Perlmutter_CC's Dr. Janice Mehnert, MD @JaniceM10. Stream LIVE here: https://t.co/vuGRUcZrG6

[Rutika Mehta @rutikamehtaMD]

How do I treat #MSIHigh #GC?

In this @Vumedi discussion, I share my approach to immunotherapy, emerging neoadjuvant data, and the evolving role of ctDNA and nonoperative management.

🎥 https://t.co/baLby4s5OE

#GastricCancer #GIOnc @nyulangone @Perlmutter_CC

[Gastroenterology & Hepatology | NYU Langone Health @NYULH_GastroHep]

A BIG congrats to @AasmaShaukatMD on receiving the @AmCollegeGastro William D. Carey Award, reserved for "an exceptional individual" who has served with distinction - demonstrating outstanding contributions in leadership, education, service, & research 👏👏👏 @MarkPochapin

[Jane Skok @jane_skok]

● How do genes communicate across long stretches of DNA? Join @leonidmirny (MIT) as he explores how rare cohesin “bridges” formed during loop extrusion may bring enhancers and promoters together—and reveals a new way CTCF can control these interactions! Save your spot today:

[American Brain Tumor Association @theABTA]

A brain tumor diagnosis can bring unique challenges for young adults and older teens.

Join our free webinar with @NYULangone.

📅 Oct. 28
⏰ 11 ET | 10 CT | 9 MT | 8 PT

Register: https://t.co/1aStC4EDXO

💬 Ask the Expert: Oct. 28–30 in the ABTA Connections community on @Inspire.

#BrainTumor #AYACancer

[Aasma Shaukat MD MPH @AasmaShaukatMD]

🌅Amazing day for @ColonCancerCoal Get your Rear in Gear 5k NYC

300 community members: survivors, friends &family met to celebrate and spread awareness about CRC

I was honored to speak on screening, knowing FH and symptoms

Bonus: Won 🥇 in my age category 🏃🏽‍♀️

@NYULH_GastroHep

[Bhavana Pothuri @BPothuri]

So proud of my star NP @Kathleen Lutz who is program chair for this meeting! Congrats on a great meeting educating Allied health professionals. @nyulangone @Perlmutter_CC

[Marc Braunstein, MD, PhD, FACP, FASCO @docbraunstein]

Join us tonight for the Long Island @BloodCancerUtd annual Light the Night walk to support research for those affected by blood cancers. @Perlmutter_CC will have a table with lots of giveaways and swag. Hope to see you there!

Fundraising team: https://t.co/t8KGxEKUIa

[NYU Grossman School of Medicine @nyugrossman]

At #OTOMTG26, our otolaryngology experts will present on facial plastic and reconstructive surgery, head and neck surgery, laryngology, sleep medicine, and care equity, quality, and safety.

See the full list of @nyulangone physicians participating: https://t.co/NxVzlfISBq

[Perlmutter Cancer Center at NYU Langone Health @Perlmutter_CC]

#MetastaticBreastCancer requires a multidisciplinary approach to treatment and quality of life. Join PCC experts & @SHARECancerSup to discuss treatment approaches, symptom management, supportive care, and quality-of-life considerations.

RSVP: https://t.co/f3jcn6vnuM